Federal Data HubHRSA 340B · JSON

START Treatment & Recovery Centers, Inc.

Starting Point · 340B ID STD100271

ParticipatingSTD

START Treatment & Recovery Centers, Inc. is a STD enrolled in the federal 340B Drug Pricing Program in New York, NY. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 9 contract-pharmacy arrangement(s) (8 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (9)

PharmacyLocationBeginTerminatedPharmacy ID
31ST & 3RD PHARMACY INCMELVILLE, NY2023-05-242026-07-0121254
31ST & 3RD PHARMACY INC.NEW YORK, NY2023-05-242026-07-01135038
870 SOUTHERN DRUG CORPBROOKLYN, NY2023-05-242026-07-0120144
AVITA PHARMACY 1040BATON ROUGE, LA2023-05-242026-07-011799
CITY DRUGS NY CORP.NEW YORK, NY2022-01-012023-02-1718575
GENOA HEALTHCARE LLCBROOKLYN, NY2025-07-012026-07-01129122
LIFE TREE PHARMACYCOLLEGEVILLE, PA2025-07-012026-07-0126184
LONGS DRUGS OF LEXINGTONLEXINGTON, SC2023-05-242026-07-0191496
PHARMBLUE LLC DBA AVITA PHARMACY 1059PHILADELPHIA, PA2023-05-242026-07-0123040

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.